FP5Individual fellowship2000–2001
Use of aziridino-y-lactone methodology for the enantiospecific preparation of novel, potential therapeutic agents for the treatment of neurodegenerative diseases.
FP5 — Improving Human Research Potential
- Duration
- 2000-03-01 → 2001-02-28
- EU contribution
- €63,000
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Participants
- Centre National de la Recherche Scientifique (CNRS) · PARISCoordinatorFrance
Links
Data: CORDIS, © European Union